For the quarter ending 2025-09-30, IPSC has $244,717K in assets. $68,369K in debts. $55,515K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 55,515 | 56,878 | ||
| Short-term investments | 77,234 | 98,965 | ||
| Prepaid expenses and other current assets | 4,960 | 4,326 | ||
| Total current assets | 137,709 | 160,169 | ||
| Property and equipment, net | 53,715 | 56,649 | ||
| Operating lease right-of-use assets | 16,566 | 27,737 | ||
| Long-term investments | - | 2,690 | ||
| Restricted cash | 2,314 | 2,709 | ||
| Intangible assets | 34,200 | 34,200 | ||
| Security deposits and non-current assets | 213 | 538 | ||
| Total assets | 244,717 | 284,692 | ||
| Accounts payable | 2,617 | 3,208 | ||
| Accrued expenses and other liabilities | 11,051 | 11,720 | ||
| Contingent consideration liability, short-term | 8,338 | - | ||
| Deposit liability | 20 | 20 | ||
| Total current liabilities | 22,026 | 14,948 | ||
| Operating lease liability, long term | 41,185 | 46,589 | ||
| Contingent consideration liability, long-term | 784 | 8,883 | ||
| Deferred tax liability | 4,374 | 4,374 | ||
| Total liabilities | 68,369 | 74,794 | ||
| Common stock, 0.0001 par value, 300,000,000 shares authorized 86,527,767 and 85,836,429 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 9 | 9 | ||
| Additional paid-in capital | 949,015 | 948,124 | ||
| Accumulated deficit | -772,740 | -738,318 | ||
| Accumulated other comprehensive income | 64 | 83 | ||
| Total stockholders' equity | 176,348 | 209,898 | ||
| Total liabilities and stockholders' equity | 244,717 | 284,692 | ||
Century Therapeutics, Inc. (IPSC)
Century Therapeutics, Inc. (IPSC)